Clinical trial Recruiting at 16 sites Observational Ages 18 and up

Comparing infection rates of a new tibia nail to standard nails after fracture fixation

Official title: Performance, Safety and Clinical Benefits of a Noble Metal Alloy-coated Intramedullary Nail: a Multicenter, Prospective Trial With a Retrospective Control

Run by Zimmer Biomet · NCT05022485 · Data updated 2026-11-12

This study is testing whether a new type of tibia nail can reduce infection rates after a leg fracture compared to standard nails in up to 500 patients.

More Tibial Fractures trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorZimmer Biomet
Industry-sponsored
Locations16 sites (Innsbruck and 15 other locations)
StatusRecruiting
StartedApril 11, 2022
Main results expectedJuly 2026
Study endsJuly 2027
Registry record updatedNovember 25, 2025
Trial IDNCT05022485 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 or older who have suffered a primary tibia fracture at high risk of infection and are eligible for intramedullary nailing.

Probably not a fit

Patients with low-risk tibial fractures or those not requiring surgical fixation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to compare the rates of fracture-related infections (FRI) between the Zimmer Natural Nail Bactiguard Tibia and conventional uncoated titanium-alloy nails 12 months after tibia fracture fixation. It will enroll up to 500 patients across 15 sites, with 250 receiving the Bactiguard device and 250 serving as retrospective controls. The study will assess safety, performance, and clinical benefits through various measures, including radiologic and clinical outcomes, as well as patient-reported quality of life. Data will be collected at multiple time points over the course of a year.

Why it matters

Potential benefit: If successful, this study could lead to reduced infection rates and improved healing outcomes for patients with tibial fractures.

How similar studies have gone: Other studies have shown promising results with similar infection prevention approaches, suggesting potential for success in this study.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient must be 18 or older.
* Patient has signed IRB/EC-approved informed consent (if applicable for retrospective controls, based on local requirements).
* Patient suffered primary tibia fracture (monolateral or bilateral) at high risk of infection, eligible for fixation by intramedullary (IM) nailing (standard or suprapatellar approach) and meets at least one of the following conditions:

  * Open fractures (incl. gunshot fractures): Gustilo Type I, II, III A and III B.
  * Delayed treatment (initial treatment by external fixation due to swelling/ high energy trauma followed by definitive treatment by intramedullary nail).
  * Fracture associated with ipsilateral leg compartment syndrome treated with fasciotomy wound(s).
  * Closed fractures with severe tissue damage: Tscherne grade C2 and C3.
* Patient:

  * will be treated with ZNN Bactiguard tibia for inclusion in investigational group (retrospective enrollment is allowed up to 1st follow-up visit);
  * was treated with uncoated (conventional) titanium-alloy intramedullary tibia nail for inclusion in control group;

Exclusion Criteria:

* Patient is unwilling or unable to give consent.
* Patient is not expected to survive follow-up schedule.
* Patient is anticipated to be non-compliant to the study protocol.
* Patient has a mental or neurological condition or alcohol/drug addiction that will not allow for proper informed consent and/or participation in follow-up program.
* Patient is a prisoner.
* Patient is known to be pregnant and/or breastfeeding.
* Patient suffered tibia fracture that meets any of the following conditions:

  * Pathologic fracture.
  * Gustilo Type IIIC open fracture.
  * Patient has multisegmented fracture NOT eligible for fixation by intramedullary nailing.
  * Patients with wound closure more than 10 days after injury.
  * Besides IM nail, patient requires additional tibia fixation by plate (additional tibia fixation by screw(s) and/or fibula plate fixation are allowed).
  * Concomitant with fracture, patient suffered head injury with Abbreviated Injury Score (AIS) ≥ 3.
* For control group:

  * patient doesn't have all the minimum required data available:

    1. demographic information
    2. injury classification
    3. FRI information
    4. operative report and device information
    5. radiographic analyses (until fracture healing or confirmation of non-union leading to reoperation)
* Tibia medullary canal is obliterated by a previous fracture or tumor\*
* Tibia bone shaft having excessive bow or a deformity\*
* Lack of bone substance or bone quality, which makes stable seating of the nail implant impossible\*
* All concomitant diseases that can impair the operation, functioning or the success of the nail implant\*
* Insufficient blood circulation\*
* Skeletally immature patients\*
* Infection\*

  * ZNN Bactiguard tibia contraindication

Where it's running

  • Tirolkliniken Innsbruck
    Innsbruck, Austria
    Recruiting
  • Hôpital Ambroise-Paré
    Boulogne-Billancourt, France
    Recruiting
  • Hôpitaux Universitaires de Marseille Nord
    Marseille, France
    Recruiting
  • Universitätsklinikum Marburg
    Marburg, Hesse, Germany
    Recruiting
  • Universitätsklinikum Leipzig
    Leipzig, Germany
    Recruiting
  • Universitätsklinikum Regensburg
    Regensburg, Germany
    Recruiting
Show 10 more locations
  • AOU Policlinico di Bari
    Bari, Italy
    Recruiting
  • Azienda Ospedaliero-Universitaria Careggi
    Florence, Italy
    Recruiting
  • Tygerberg Hospital
    Cape Town, South Africa
    Recruiting
  • Groote Schuur Hospital
    Cape Town, South Africa
    Recruiting
  • Hospital Universitario Valle de Hebrón
    Barcelona, Catalonia, Spain
    Recruiting
  • Kantonsspital Winterthur
    Winterthur, Canton of Zurich, Switzerland
    Recruiting
  • Royal Infirmary of Edinburgh
    Edinburgh, United Kingdom
    Recruiting
  • Leeds General Infirmary
    Leeds, United Kingdom
    Recruiting
  • The Royal London Hospital
    London, United Kingdom
    Recruiting
  • King's College Hospital NHS Trust
    London, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.